Public signalCompany raiseAuto-indexed · Unverified
Avicenna Biosciences, Inc. raised $71K
Avicenna Biosciences, Inc.· DURHAM, US· Biotechnology· Filed Oct 30, 2025
Avicenna Biosciences, Inc. reported raising capital. Based in DURHAM, NORTH CAROLINA, US. First sale reported 2022-02-17. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$70,650
Confidence90%
On the record
- Location
- DURHAM, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $70,650
- Target amount
- $70,650
- Filing date
- Oct 30, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Sources & provenance
“Operating company sold 70,650 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Oct 30, 2025. Details beyond the filing have not been verified.
Tags
AmendmentUSCompanyBiotechnologyUnder $100KCompany Raise
Are you associated with Avicenna Biosciences, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record